MedTrace Logo

Association Between Cerebral Arterial Vascular Flow and Sleep Apnea in Neurodegenerative Alterations

NCT02578303 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2020-07-14

No results posted yet for this study

Summary

Obstructive sleep apnea syndrome (OSAS) is a sleep-disordered breathing characterized by the occurrence of repeated upper airway obstructions leading to airflow reduction (hypopnea) or cessation (apnea). The apnea-hypopnea index (AHI) is the number of apneas and hypopneas per hour of sleep. OSA patients often report cognitive complaints.

About 25% of the elderly population is affected by this syndrome with a drastic increase of this rate among dementia patients. OSAS is considered to be an important risk factor for the development of hypertension, heart disease and stroke.

Conditions

  • Alzheimer Disease

Interventions

OTHER

Vascular flow measurement by PC-MRI

participants will undergo vascular flow measurement by PC-MRI at intra and extracranial levels

Sponsors & Collaborators

  • Central Hospital Saint Quentin

    lead OTHER_GOV

Principal Investigators

  • ATTIER Jadwiga, MD · CH SAINT-QUENTIN

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
75 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2022-01-01
Completion
2022-01-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02578303 on ClinicalTrials.gov